This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paolo G. Miotti, MD, MPH; Kenrad E. Nelson, MD; Gina A. Dallabetta, MD; Homayoon Farzadegan, PhD; Joseph Margolick, MD, PhD; Mary Lou Clements, MD, MPH

JAMA. 1989;262(6):779-783.

Abstract
We studied whether a two-dose regimen of inactivated influenza virus vaccine was more effective than a single dose in inducing protective hemagglutinationinhibition antibody responses in patients infected with human immunodeficiency virus (HIV). Participants included subjects with acquired immunodeficiency syndrome, subjects with acquired immunodeficiency syndrome—related complex, and HIV-seropositive individuals with either lymphadenopathy only or no symptoms. Control subjects were HIV-seronegative heterosexuals and HIV-seronegative homosexuals. Two doses of inactivated influenza vaccine containing 15 µg of the hemagglutinin of influenza A/Taiwan/1/86(H1N1), A/Leningrad/360/86(H3N2), and B/Ann Arbor/1/86 were administered intramuscularly in the deltoid region 1 month apart. The second dose of vaccine did not significantly increase the frequency or magnitude of antibody responses of either HIV-seropositive or HIV-seronegative subjects over that achieved by a single dose. The two-dose regimen induced a protective level (1:64) of hemagglutination-inhibition antibody to influenza A(H1N1) or (H3N2) virus less often in subjects with symptomatic HIV infection than in uninfected control subjects (39% vs 87% or 46% vs 97%, respectively). Our results suggest that a substantial proportion of individuals with symptomatic HIV infection might remain unprotected from influenza, even after immunization with a two-dose regimen.

(JAMA. 1989;262:779-783)

Author Affiliations
From the Departments of Epidemiology (Drs Miotti, Nelson, Dallabetta, and Farzadegan), International Health (Dr Clements), Environmental Health Sciences (Dr Margolick), and Medicine (Drs Nelson, Dallabetta, and Clements), The Johns Hopkins School of Hygiene and Public Health and School of Medicine, Baltimore, Md.

Footnotes
Reprint requests to Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health, 615 N Wolfe St, Baltimore, MD 21205 (Dr Nelson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals
Malaspina et al.
J. Immunol. 2008;181:1199-1206.
ABSTRACT | FULL TEXT  

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection
De Milito et al.
Blood 2004;103:2180-2186.
ABSTRACT | FULL TEXT  

Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function
Malaspina et al.
J. Immunol. 2003;170:5965-5972.
ABSTRACT | FULL TEXT  

Technical Report: Reduction of the Influenza Burden in Children
Rennels et al.
Pediatrics 2002;110:e80-e80.
ABSTRACT | FULL TEXT  

Efficacy of Influenza Vaccination in HIV-Infected Persons: A Randomized, Double-Blind, Placebo-Controlled Trial
Tasker et al.
ANN INTERN MED 1999;131:430-433.
ABSTRACT | FULL TEXT  

Possible Role of Interleukin-10 (IL-10) and CD40 Ligand Expression in the Pathogenesis of Hypergammaglobulinemia in Human Immunodeficiency Virus Infection: Modulation of IL-10 and Ig Production After Intravenous Ig Infusion
Muller et al.
Blood 1998;92:3721-3729.
ABSTRACT | FULL TEXT  

Comparison of Neutralizing and Hemagglutination-Inhibiting Antibody Responses to Influenza A Virus Vaccination of Human Immunodeficiency Virus-Infected Individuals
Benne et al.
CVI 1998;5:114-117.
ABSTRACT | FULL TEXT  

Prevention of Respiratory Infections in Adults: Influenza and Pneumococcal Vaccines
Fiebach and Beckett
Arch Intern Med 1994;154:2545-2557.
ABSTRACT  

Preventive Health Care for Adults With HIV Infection
Jewett and Hecht
JAMA 1993;269:1144-1153.
ABSTRACT  

Infections in HIV-infected Travelers: Risks and Prevention
Wilson et al.
ANN INTERN MED 1991;114:582-591.
ABSTRACT  

DOUBLE-DOSE OF FLU VACCINE DOES NOT PROTECT SYMPTOMATIC HIV-INFECTED PATIENTS
JWatch General 1989;1989:7-7.
FULL TEXT